Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust SMID Rising Dividend Achievers UCITS ETF 26.05.2026 SDVY.LN IE0001R850E1 14,604,007.00 USD 366,961,287.55 25.127  ...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Growth Strength UCITS ETF 26.05.2026 FTGS.LN IE000YZLMXT9 25,002.00 USD 578,248.97 23.128  ...

CARLSBAD, Calif. & SAN JOSE, Calif.--(BUSINESS WIRE)--MaxLinear and GCT Semiconductor Partner to Develop Next-Generation 5G FWA and Converged Gateways...

LONDON--(BUSINESS WIRE)--Confidence in project delivery among UK business leaders has surged since the start of 2026, rising from 46% in January to 87% in April, according to new research from Association for Project Management (APM). The findings from APM (a year-long survey of 500 CEOs and Managing Directors in the UK in partnership with Censuswide), suggest organisations are moving beyond early-year uncertainty and increasingly crediting strong leadership, professional development and access...

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health is advancing its commitment to improving healthcare access by addressing one of healthcare’s most pressing challenges: the digital divide. Through innovative programs like Get Connected for Health and services offered by CareBridge, a subsidiary of Elevance Health, the company is helping ensure that individuals - especially those in underserved communities - have the tools, connectivity, and support needed to help them better manage their healthcar...

LONDON--(BUSINESS WIRE)--Capri Holdings Limited (NYSE:CPRI), a global fashion luxury group, today announced its financial results for the fourth quarter and full year Fiscal 2026 ended March 28, 2026. Fourth Quarter Fiscal 2026 Highlights from Continuing Operations Revenue decreased 3.7% on a reported basis and 7.0% in constant currency Operating margin of (3.4)%; adjusted operating margin of (0.1)% Loss per share of $(0.01); adjusted earnings per share of $0.22 John D. Idol, the Company’s Chai...

ROSEMONT, Ill.--(BUSINESS WIRE)--US Foods Holding Corp. (NYSE: USFD) announced today that Dave Flitman, Chair of the Board and Chief Executive Officer, and Dirk Locascio, Chief Financial Officer, will participate in a fireside chat at the Deutsche Bank Access Global Consumer Conference on Wednesday, June 3, 2026, at 7:00 a.m. CDT or 2:00 p.m. CEST. Media and investors can listen to a live audio webcast by visiting the Investor Relations page of the company’s website at https://ir.usfoods.com/ev...

PARAMUS, N.J.--(BUSINESS WIRE)--Movado Group, Inc. (NYSE: MOV) today announced first quarter fiscal 2027 results for the period ended April 30, 2026. First Quarter Fiscal 2027 Highlights Net sales of $142.4 million versus $131.8 million in the first quarter of fiscal 2026; Gross margin of 57.3% compared to 54.1% in the first quarter of fiscal 2026; Operating income of $7.0 million compared to $0.3 million in the first quarter of fiscal 2026; Adjusted operating income of $7.5 million compared to...

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced that it registered certain state-licensed medical cannabis facilities with the U.S. Drug Enforcement Administration (“DEA”) following the federal rescheduling of medical cannabis to Schedule III under the Controlled Substances...